Charles River Laboratories International, Inc.
NYSE:CRL
210.29 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,129.409 | 3,976.06 | 3,540.16 | 2,923.933 | 2,621.226 | 2,266.096 | 1,857.601 | 1,681.432 | 1,363.302 | 1,297.662 | 1,165.528 | 1,129.53 | 1,142.647 | 1,133.416 | 1,202.551 | 1,343.493 | 1,230.626 | 1,058.385 | 1,122.228 | 766.917 | 613.723 | 554.629 | 465.63 | 306.585 | 219.276 | 193.301 |
| Cost of Revenue
| 2,626.853 | 2,513.409 | 2,205.522 | 1,850.392 | 1,662.915 | 1,426.029 | 1,155.287 | 1,034.766 | 832.21 | 825.002 | 770.626 | 737.449 | 740.405 | 748.656 | 773.183 | 832.784 | 752.435 | 651.778 | 693.493 | 468.351 | 380.058 | 345.646 | 298.379 | 171.45 | 120.905 | 122.547 |
| Gross Profit
| 1,502.556 | 1,462.651 | 1,334.638 | 1,073.541 | 958.311 | 840.067 | 702.314 | 646.666 | 531.092 | 472.66 | 394.902 | 392.081 | 402.242 | 384.76 | 429.368 | 510.709 | 478.191 | 406.607 | 428.735 | 298.566 | 233.665 | 208.983 | 167.251 | 135.135 | 98.371 | 70.754 |
| Gross Profit Ratio
| 0.364 | 0.368 | 0.377 | 0.367 | 0.366 | 0.371 | 0.378 | 0.385 | 0.39 | 0.364 | 0.339 | 0.347 | 0.352 | 0.339 | 0.357 | 0.38 | 0.389 | 0.384 | 0.382 | 0.389 | 0.381 | 0.377 | 0.359 | 0.441 | 0.449 | 0.366 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 747.855 | 665.098 | 619.919 | 528.935 | 517.622 | 443.854 | 373.446 | 367.548 | 300.414 | 269.033 | 225.695 | 208.248 | 206.14 | 262.489 | 233.995 | 230.159 | 217.491 | 180.795 | 189.544 | 121.448 | 90.236 | 83.303 | 68.315 | 51.204 | 39.765 | 34.142 |
| Other Expenses
| 95.537 | 146.578 | 124.857 | 111.877 | 89.538 | 13.258 | 38.544 | 11.897 | 3.008 | 10.721 | 7.165 | -3.266 | 21.796 | 24.405 | 28.447 | 30.312 | 33.509 | 37.639 | 58.172 | 16.795 | 4.876 | 3.414 | 8.653 | 18.87 | 15.643 | 1.287 |
| Operating Expenses
| 885.295 | 811.676 | 744.776 | 640.812 | 607.16 | 508.684 | 414.816 | 409.247 | 324.643 | 294.99 | 243.501 | 226.316 | 227.936 | 286.894 | 262.442 | 260.471 | 251 | 218.434 | 247.716 | 138.243 | 95.112 | 86.717 | 76.968 | 70.074 | 55.408 | 35.429 |
| Operating Income
| 617.261 | 650.975 | 589.862 | 432.729 | 351.151 | 331.383 | 287.498 | 237.419 | 206.449 | 177.67 | 151.401 | 165.765 | 174.306 | -298.512 | 166.926 | -449.762 | 227.191 | 188.173 | 181.019 | 160.323 | 138.553 | 122.266 | 90.283 | 65.061 | 42.963 | 35.325 |
| Operating Income Ratio
| 0.149 | 0.164 | 0.167 | 0.148 | 0.134 | 0.146 | 0.155 | 0.141 | 0.151 | 0.137 | 0.13 | 0.147 | 0.153 | -0.263 | 0.139 | -0.335 | 0.185 | 0.178 | 0.161 | 0.209 | 0.226 | 0.22 | 0.194 | 0.212 | 0.196 | 0.183 |
| Total Other Income Expenses Net
| 95.537 | -27.988 | -109.152 | 14.385 | -47.067 | 13.258 | 38.544 | 11.897 | 3.008 | 10.721 | 7.165 | -3.266 | -0.411 | -397.855 | 2.086 | -705.93 | -1.448 | 0.981 | -0.174 | 0.723 | 0.783 | 1.538 | 0.972 | 1.096 | 1.997 | -0.058 |
| Income Before Tax
| 581.284 | 622.987 | 480.71 | 447.114 | 304.084 | 281.681 | 296.955 | 222.921 | 195.428 | 177.595 | 138.327 | 129.746 | 132.662 | -334.082 | 149.107 | -461.01 | 217.422 | 176.564 | 160.413 | 152.525 | 132.63 | 114.403 | 69.479 | 25.714 | 32.685 | 35.832 |
| Income Before Tax Ratio
| 0.141 | 0.157 | 0.136 | 0.153 | 0.116 | 0.124 | 0.16 | 0.133 | 0.143 | 0.137 | 0.119 | 0.115 | 0.116 | -0.295 | 0.124 | -0.343 | 0.177 | 0.167 | 0.143 | 0.199 | 0.216 | 0.206 | 0.149 | 0.084 | 0.149 | 0.185 |
| Income Tax Expense
| 100.914 | 130.379 | 81.873 | 81.808 | 50.023 | 54.463 | 171.369 | 66.835 | 43.391 | 47.671 | 32.911 | 27.628 | 17.14 | 0.023 | 39.725 | 61.944 | 59.4 | 49.738 | 16.576 | 61.156 | 51.063 | 43.572 | 27.095 | 7.837 | 15.561 | 14.123 |
| Net Income
| 474.624 | 486.226 | 390.982 | 364.304 | 252.019 | 226.373 | 123.355 | 154.765 | 149.313 | 126.698 | 102.828 | 97.295 | 109.566 | -336.669 | 114.441 | -521.843 | 154.406 | -55.783 | 141.999 | 89.792 | 80.151 | 50.132 | 35.407 | -11.224 | 17.124 | 23.378 |
| Net Income Ratio
| 0.115 | 0.122 | 0.11 | 0.125 | 0.096 | 0.1 | 0.066 | 0.092 | 0.11 | 0.098 | 0.088 | 0.086 | 0.096 | -0.297 | 0.095 | -0.388 | 0.125 | -0.053 | 0.127 | 0.117 | 0.131 | 0.09 | 0.076 | -0.037 | 0.078 | 0.121 |
| EPS
| 9.27 | 9.57 | 7.77 | 7.35 | 5.17 | 4.72 | 2.6 | 3.29 | 3.21 | 2.72 | 2.15 | 2.03 | 2.16 | -5.38 | 1.75 | -7.76 | 2.31 | -0.81 | 2.04 | 1.81 | 1.76 | 1.12 | 0.86 | -0.4 | 0.86 | 2.27 |
| EPS Diluted
| 9.22 | 9.48 | 7.6 | 7.2 | 5.07 | 4.62 | 2.54 | 3.23 | 3.13 | 2.66 | 2.12 | 2.01 | 2.14 | -5.38 | 1.74 | -7.76 | 2.25 | -0.8 | 1.96 | 1.67 | 1.64 | 1.06 | 0.8 | -0.35 | 0.86 | 2.27 |
| EBITDA
| 1,032.118 | 986.148 | 820.16 | 768.471 | 563.061 | 410.283 | 368.102 | 292.329 | 230.678 | 203.627 | 169.207 | 183.833 | 196.102 | 122.271 | 193.287 | 986.48 | 317.555 | 272.322 | 285.83 | 207.776 | 168.891 | 146.771 | 118.361 | 82.835 | 56.609 | 46.278 |
| EBITDA Ratio
| 0.25 | 0.248 | 0.232 | 0.263 | 0.215 | 0.181 | 0.198 | 0.174 | 0.169 | 0.157 | 0.145 | 0.163 | 0.172 | 0.108 | 0.161 | 0.734 | 0.258 | 0.257 | 0.255 | 0.271 | 0.275 | 0.265 | 0.254 | 0.27 | 0.258 | 0.239 |